Cargando…

Colocalization of somatostatin receptors and epidermal growth factor receptors in breast cancer cells

BACKGROUND: Somatostatin receptor (SSTR) expression is positively correlated with tumor size and inversely correlated with epidermal growth factor receptor (ErbB) levels and tumor differentiation. In the present study, we compared SSTR1-5 and ErbB1-4 mRNA and protein expression in two breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watt, Heather L, Kumar, Ujendra
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1479379/ https://www.ncbi.nlm.nih.gov/pubmed/16519802 http://dx.doi.org/10.1186/1475-2867-6-5

Ejemplares similares

Inhibition of tumor promoting signals by activation of SSTR2 and opioid receptors in human breast cancer cells
por: Kharmate, Geetanjali, et al.
Publicado: (2013)

Parthenolide inhibits the growth of non-small cell lung cancer by targeting epidermal growth factor receptor
por: Li, Xiaoling, et al.
Publicado: (2020)

Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin Receptors
por: Somvanshi, Rishi K., et al.
Publicado: (2012)

Differential regulation of somatostatin receptors 1 and 2 mRNA and protein expression by tamoxifen and estradiol in breast cancer cells
por: Rivera, Juan A, et al.
Publicado: (2005)

δ-Opioid Receptor and Somatostatin Receptor-4 Heterodimerization: Possible Implications in Modulation of Pain Associated Signaling
por: Somvanshi, Rishi K., et al.
Publicado: (2014)

Morphologic transformation of human breast epithelial cells MCF-10A: dependence on an oxidative microenvironment and estrogen/epidermal growth factor receptors
por: Yusuf, Rita, et al.
Publicado: (2010)

Stress-induced endocytosis and degradation of epidermal growth factor receptor are two independent processes
por: Peng, Ke, et al.
Publicado: (2016)

Heterodimerization of β(2 )adrenergic receptor and somatostatin receptor 5: Implications in modulation of signaling pathway
por: Somvanshi, Rishi K, et al.
Publicado: (2011)

Involvement of the epidermal growth factor receptor in the modulation of multidrug resistance in human hepatocellular carcinoma cells in vitro
por: Hoffmann, Katrin, et al.
Publicado: (2011)

The effect of epiregulin on epidermal growth factor receptor expression and proliferation of oral squamous cell carcinoma cell lines
por: Kong, Darren Chyi-Hsiang, et al.
Publicado: (2014)

Coexpression of human somatostatin receptor-2 (SSTR2) and SSTR3 modulates antiproliferative signaling and apoptosis
por: War, Sajad A, et al.
Publicado: (2012)

A cross-talk between integrin β4 and epidermal growth factor receptor induces gefitinib chemoresistance to gastric cancer
por: Huafeng, Jia, et al.
Publicado: (2018)

Role of Somatostatin in the Regulation of Central and Peripheral Factors of Satiety and Obesity
por: Kumar, Ujendra, et al.
Publicado: (2020)

Epidermal Growth Factor Receptors and Breast Cancer
por: Farndon, J. R., et al.
Publicado: (1989)

Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE
por: Tannheimer, Stacey L, et al.
Publicado: (2000)

The epidermal growth factor receptor family in breast cancer
por: Koutras, Angelos K, et al.
Publicado: (2008)

Receptor-bound somatostatin and epidermal growth factor are processed differently in GH4C1 rat pituitary cells
Publicado: (1986)

Assessment of gene expression of intracellular calcium channels, pumps and exchangers with epidermal growth factor-induced epithelial-mesenchymal transition in a breast cancer cell line
por: Davis, Felicity M, et al.
Publicado: (2013)

Coamplification with Colocalization of the Human Epidermal Growth Factor Receptor 2 and Centromeric-17 Signals on Fluorescence In Situ Hybridization in Invasive Breast Carcinoma: An Exceedingly Rare Finding
por: Pai, T, et al.
Publicado: (2016)

The in vitro influences of epidermal growth factor and heregulin-β1 on the efficacy of trastuzumab used in Her-2 positive breast adenocarcinoma
por: Hurrell, Tracey, et al.
Publicado: (2013)

Somatostatin Receptor 1 and 5 Double Knockout Mice Mimic Neurochemical Changes of Huntington's Disease Transgenic Mice
por: Rajput, Padmesh S., et al.
Publicado: (2011)

Epidermal growth factor-mediated Rab25 pathway regulates integrin β1 trafficking in colon cancer
por: Hong, Kyung Sook, et al.
Publicado: (2018)

Epidermal growth factor receptor and oestrogen receptors in the non-malignant part of the cancerous breast.
por: Barker, S., et al.
Publicado: (1989)

Expression of osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, tumor necrosis factor-related apoptosis-inducing ligand, stromal cell-derived factor-1 and their receptors in epithelial metastatic breast cancer cell lines
por: Labovsky, Vivian, et al.
Publicado: (2012)

Osteopontin’s colocalization with the adhesion molecule CEACAM5 in cytoplasm of carcinoma of tongue and its correlation with the invasion of that diease
por: Zhang, Fan, et al.
Publicado: (2012)

Epidermal growth factor receptor in breast cancer. Comparison with non malignant breast tissue.
por: Dittadi, R., et al.
Publicado: (1993)

Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis
por: Maaroufi, Younes, et al.
Publicado: (2000)

Curcumin inhibits leptin gene expression and secretion in breast cancer cells by estrogen receptors
por: Nejati-Koshki, Kazem, et al.
Publicado: (2014)

Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers
por: Turk, Casey M, et al.
Publicado: (2012)

Epidermal Growth Factor Receptor in Pancreatic Cancer
por: Oliveira-Cunha, Melissa, et al.
Publicado: (2011)

Epidermal growth factor receptor status of histological sub-types of breast cancer.
por: Sainsbury, J. R., et al.
Publicado: (1988)

ZMIZ2 promotes the development of triple-receptor negative breast cancer
por: Zou, Xiaopan, et al.
Publicado: (2022)

Somatostatin-Mediated Regulation of Retinoic Acid-Induced Differentiation of SH-SY5Y Cells: Neurotransmitters Phenotype Characterization
por: Singh, Sneha, et al.
Publicado: (2022)

Clinical activities of the epidermal growth factor receptor family inhibitors in breast cancer
por: Henson, Elizabeth S, et al.
Publicado: (2007)

Mutations of the Epidermal Growth Factor Receptor Gene in Triple-Negative Breast Cancer
por: Kim, Aeri, et al.
Publicado: (2017)

Cardiotoxicity of Epidermal Growth Factor Receptor 2-Targeted Drugs for Breast Cancer
por: Yang, ZiYan, et al.
Publicado: (2021)

Interleukin-4 receptor and epidermal growth factor receptor expression in colorectal cancer.
por: Kaklamanis, L., et al.
Publicado: (1992)

The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer
por: Chang, Shih-Chieh, et al.
Publicado: (2011)

Oncogenic fingerprint of epidermal growth factor receptor pathway and emerging epidermal growth factor receptor blockade resistance in colorectal cancer
por: Sobani, Zain A, et al.
Publicado: (2016)

Deregulation of angiopoietin-like 4 slows ovarian cancer progression through vascular endothelial growth factor receptor 2 phosphorylation
por: Wu, Yuxian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1k01ftjh840ahl0n0qf9tbt979